Gene Solutions Announces Strategic Entry into Türkiye with Robust Real-World Evidence at the 2nd International Hereditary Cancers Congress 2026

Gene Solutions Announces Strategic Entry into Türkiye with Robust Real-World Evidence at the 2nd International Hereditary Cancers Congress 2026

In Partnership with ATC Genomics, the Company Presented One of Asia's Largest Real-World Datasets (n=12,281) for AI-Powered Multi-Cancer Early Detection (MCED) and Showcased its Clinically Validated ctDNA-Powered Oncology Portfolio Across the Full...

ImmVira's Oncolytic Product MVR-T3011 Expanded to BCG-Naïve Bladder Cancer Patients for the First Time with Clinical Data Presented at the 2026 ASCO GU Conference

ImmVira's Oncolytic Product MVR-T3011 Expanded to BCG-Naïve Bladder Cancer Patients for the First Time with Clinical Data Presented at the 2026 ASCO GU Conference

SUZHOU, China, Feb. 27, 2026 /PRNewswire/ -- Intravesical BCG is the standard of care (SOC) for BCG-naive high-risk non-muscle-invasive bladder cancer (NMIBC) patients. However, the scarcity of BCG products has become a global phenomenon, and...

The Exhibition of Achievements in Compiling A Comprehensive Collection of Ancient Chinese Paintings Opens in Hong Kong with Academic Symposium

The Exhibition of Achievements in Compiling A Comprehensive Collection of Ancient Chinese Paintings Opens in Hong Kong with Academic Symposium

HONG KONG, Jan. 31, 2026 /PRNewswire/ -- The Compilation of Classics in the Flourishing Age: Exhibition of Achievements in Compiling A Comprehensive Collection of Ancient Chinese Paintings is on display at the City University of Hong Kong (CityUHK)...

Antengene Presents at JPM: Strong Clinical Data Update and Strategic Focus on Next-Generation ADCs and TCEs

Antengene Presents at JPM: Strong Clinical Data Update and Strategic Focus on Next-Generation ADCs and TCEs

SHANGHAI and HONG KONG, Jan. 16, 2026 /PRNewswire/ -- Antengene Corporation Limited (" Antengene ", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class...

Neurophet Participates RSNA 2025, Showcased Real-World Clinical Use Cases of 'Neurophet AQUA AD'

Neurophet Participates RSNA 2025, Showcased Real-World Clinical Use Cases of 'Neurophet AQUA AD'

Demonstrated brain imaging analysis solutions, including 'Neurophet AQUA AD,' which enables monitoring of adverse effects associated with Alzheimer's disease treatments Highlighted clinical cases that improved the safety of anti-amyloid therapy...

Crown Prince of Selangor Officiates Launch of UNESCO Southeast Asia Entrepreneurship Education Network in Kuala Lumpur

Crown Prince of Selangor Officiates Launch of UNESCO Southeast Asia Entrepreneurship Education Network in Kuala Lumpur

A Landmark Moment Aligning ASEAN Youth Empowerment with Regional Education Transformation KUALA LUMPUR, Malaysia, Nov. 27, 2025 /PRNewswire/ -- His Highness Tengku Amir Shah ibni Sultan Sharafuddin Idris Shah Al-Haj, Crown Prince of Selangor,...

Ping An Unveils "Ancient Tree Guardian Action" at UN Climate Change Conference (COP30)

Ping An Unveils "Ancient Tree Guardian Action" at UN Climate Change Conference (COP30)

Leveraging an Innovative "Insurance + Technology" Approach to Safeguard 55,000 Ancient Trees and Promote Biodiversity Conservation HONG KONG and SHANGHAI, Nov. 24, 2025 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. ("Ping An" or...

Chinese-Style Green Wisdom: Global Gen Z Discovers Jinan's Charm Through Culture and Innovation

Chinese-Style Green Wisdom: Global Gen Z Discovers Jinan's Charm Through Culture and Innovation

BEIJING, Nov. 10, 2025 /PRNewswire/ -- A news report from China Daily: At the Quehua Ecological and Cultural Zone in Jinan Start-up Area for Growth Drivers Transformation, Shandong Province, French youth RIVOIRE Oceane Anna, along with her peers,...

Kelun-Biotech Presented TROP2 ADC Sacituzumab Tirumotecan Results From Multiple Clinical Studies at the 2025 CCHIO Congress

Kelun-Biotech Presented TROP2 ADC Sacituzumab Tirumotecan Results From Multiple Clinical Studies at the 2025 CCHIO Congress

CHENGDU, China, Nov. 10, 2025 /PRNewswire/ -- From November 6 to 9, the 2025 Chinese Congress on Holistic Integrative Oncology (CCHIO) was held in Kunming, Yunnan. This conference was jointly organized by the Chinese Anti-Cancer Association (CACA),...

Kelun-Biotech Presents Positive Phase 3 Data for Trastuzumab Botidotin Compared to T-DM1 at 2025 ESMO

Kelun-Biotech Presents Positive Phase 3 Data for Trastuzumab Botidotin Compared to T-DM1 at 2025 ESMO

CHENGDU, China, Oct. 20, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held in Berlin, Germany, Results from a Phase 3 study of...

  • 1
  • 2
  • 3
  • 4
  • menu
    menu